The global market for Chronic Urticaria Or Hives Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Urticaria Or Hives Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chronic Urticaria Or Hives Drug by region & country, by Type, and by Application.

The Chronic Urticaria Or Hives Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Urticaria Or Hives Drug.

Market Segmentation

Scope of Chronic Urticaria Or Hives Drug - Market Report

Report Metric	Details
Report Name	Chronic Urticaria Or Hives Drug - Market
CAGR	5%
Segment by Type:	GDC-0853 GSK-2646264 BF-Derm-1 Bilastine Others
Segment by Application	Clinic Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited, Merck & Co., Inc., Mycenax Biotech Inc., Novartis AG, Panacea Biotec Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chronic Urticaria Or Hives Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Chronic Urticaria Or Hives Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Chronic Urticaria Or Hives Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Chronic Urticaria Or Hives Drug - Market report?

Ans: The main players in the Chronic Urticaria Or Hives Drug - Market are AstraZeneca Plc, Biofrontera AG, ELORAC, Inc., Faes Farma, SA, Genentech, Inc., GlaxoSmithKline Plc, J Uriach Y Compania, S.A., Mabtech Limited, Merck & Co., Inc., Mycenax Biotech Inc., Novartis AG, Panacea Biotec Limited

What are the Application segmentation covered in the Chronic Urticaria Or Hives Drug - Market report?

Ans: The Applications covered in the Chronic Urticaria Or Hives Drug - Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Chronic Urticaria Or Hives Drug - Market report?

Ans: The Types covered in the Chronic Urticaria Or Hives Drug - Market report are GDC-0853, GSK-2646264, BF-Derm-1, Bilastine, Others

1 Market Overview

1.1 Chronic Urticaria Or Hives Drug Product Introduction

1.2 Global Chronic Urticaria Or Hives Drug Market Size Forecast

1.2.1 Global Chronic Urticaria Or Hives Drug Sales Value (2019-2030)

1.2.2 Global Chronic Urticaria Or Hives Drug Sales Volume (2019-2030)

1.2.3 Global Chronic Urticaria Or Hives Drug Sales Price (2019-2030)

1.3 Chronic Urticaria Or Hives Drug Market Trends & Drivers

1.3.1 Chronic Urticaria Or Hives Drug Industry Trends

1.3.2 Chronic Urticaria Or Hives Drug Market Drivers & Opportunity

1.3.3 Chronic Urticaria Or Hives Drug Market Challenges

1.3.4 Chronic Urticaria Or Hives Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Chronic Urticaria Or Hives Drug Players Revenue Ranking (2023)

2.2 Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024)

2.3 Global Chronic Urticaria Or Hives Drug Players Sales Volume Ranking (2023)

2.4 Global Chronic Urticaria Or Hives Drug Sales Volume by Company Players (2019-2024)

2.5 Global Chronic Urticaria Or Hives Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Chronic Urticaria Or Hives Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Chronic Urticaria Or Hives Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Chronic Urticaria Or Hives Drug

2.9 Chronic Urticaria Or Hives Drug Market Competitive Analysis

2.9.1 Chronic Urticaria Or Hives Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Chronic Urticaria Or Hives Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 GDC-0853

3.1.2 GSK-2646264

3.1.3 BF-Derm-1

3.1.4 Bilastine

3.1.5 Others

3.2 Global Chronic Urticaria Or Hives Drug Sales Value by Type

3.2.1 Global Chronic Urticaria Or Hives Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Chronic Urticaria Or Hives Drug Sales Value, by Type (2019-2030)

3.2.3 Global Chronic Urticaria Or Hives Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Chronic Urticaria Or Hives Drug Sales Volume by Type

3.3.1 Global Chronic Urticaria Or Hives Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Chronic Urticaria Or Hives Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Chronic Urticaria Or Hives Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Chronic Urticaria Or Hives Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinic

4.1.2 Hospital

4.1.3 Others

4.2 Global Chronic Urticaria Or Hives Drug Sales Value by Application

4.2.1 Global Chronic Urticaria Or Hives Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Chronic Urticaria Or Hives Drug Sales Value, by Application (2019-2030)

4.2.3 Global Chronic Urticaria Or Hives Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Chronic Urticaria Or Hives Drug Sales Volume by Application

4.3.1 Global Chronic Urticaria Or Hives Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Chronic Urticaria Or Hives Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Chronic Urticaria Or Hives Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Chronic Urticaria Or Hives Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Chronic Urticaria Or Hives Drug Sales Value by Region

5.1.1 Global Chronic Urticaria Or Hives Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Chronic Urticaria Or Hives Drug Sales Value by Region (2019-2024)

5.1.3 Global Chronic Urticaria Or Hives Drug Sales Value by Region (2025-2030)

5.1.4 Global Chronic Urticaria Or Hives Drug Sales Value by Region (%), (2019-2030)

5.2 Global Chronic Urticaria Or Hives Drug Sales Volume by Region

5.2.1 Global Chronic Urticaria Or Hives Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2019-2024)

5.2.3 Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2025-2030)

5.2.4 Global Chronic Urticaria Or Hives Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

5.4.2 North America Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

5.5.2 Europe Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

5.7.2 South America Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value

6.2.1 Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.3.2 United States Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.4.2 Europe Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.5.2 China Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.6.2 Japan Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.7.2 South Korea Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Chronic Urticaria Or Hives Drug Sales Value, 2019-2030

6.9.2 India Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Chronic Urticaria Or Hives Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AstraZeneca Plc

7.1.1 AstraZeneca Plc Company Information

7.1.2 AstraZeneca Plc Introduction and Business Overview

7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offerings

7.1.5 AstraZeneca Plc Recent Development

7.2 Biofrontera AG

7.2.1 Biofrontera AG Company Information

7.2.2 Biofrontera AG Introduction and Business Overview

7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Product Offerings

7.2.5 Biofrontera AG Recent Development

7.3 ELORAC, Inc.

7.3.1 ELORAC, Inc. Company Information

7.3.2 ELORAC, Inc. Introduction and Business Overview

7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offerings

7.3.5 ELORAC, Inc. Recent Development

7.4 Faes Farma, SA

7.4.1 Faes Farma, SA Company Information

7.4.2 Faes Farma, SA Introduction and Business Overview

7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offerings

7.4.5 Faes Farma, SA Recent Development

7.5 Genentech, Inc.

7.5.1 Genentech, Inc. Company Information

7.5.2 Genentech, Inc. Introduction and Business Overview

7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offerings

7.5.5 Genentech, Inc. Recent Development

7.6 GlaxoSmithKline Plc

7.6.1 GlaxoSmithKline Plc Company Information

7.6.2 GlaxoSmithKline Plc Introduction and Business Overview

7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offerings

7.6.5 GlaxoSmithKline Plc Recent Development

7.7 J Uriach Y Compania, S.A.

7.7.1 J Uriach Y Compania, S.A. Company Information

7.7.2 J Uriach Y Compania, S.A. Introduction and Business Overview

7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offerings

7.7.5 J Uriach Y Compania, S.A. Recent Development

7.8 Mabtech Limited

7.8.1 Mabtech Limited Company Information

7.8.2 Mabtech Limited Introduction and Business Overview

7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Product Offerings

7.8.5 Mabtech Limited Recent Development

7.9 Merck & Co., Inc.

7.9.1 Merck & Co., Inc. Company Information

7.9.2 Merck & Co., Inc. Introduction and Business Overview

7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offerings

7.9.5 Merck & Co., Inc. Recent Development

7.10 Mycenax Biotech Inc.

7.10.1 Mycenax Biotech Inc. Company Information

7.10.2 Mycenax Biotech Inc. Introduction and Business Overview

7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offerings

7.10.5 Mycenax Biotech Inc. Recent Development

7.11 Novartis AG

7.11.1 Novartis AG Company Information

7.11.2 Novartis AG Introduction and Business Overview

7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Product Offerings

7.11.5 Novartis AG Recent Development

7.12 Panacea Biotec Limited

7.12.1 Panacea Biotec Limited Company Information

7.12.2 Panacea Biotec Limited Introduction and Business Overview

7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offerings

7.12.5 Panacea Biotec Limited Recent Development

8 Industry Chain Analysis

8.1 Chronic Urticaria Or Hives Drug Industrial Chain

8.2 Chronic Urticaria Or Hives Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Chronic Urticaria Or Hives Drug Sales Model

8.5.2 Sales Channel

8.5.3 Chronic Urticaria Or Hives Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

J Uriach Y Compania, S.A.

Panacea Biotec Limited

List of Tables

Table 1. Chronic Urticaria Or Hives Drug Market Trends

Table 2. Chronic Urticaria Or Hives Drug Market Drivers & Opportunity

Table 3. Chronic Urticaria Or Hives Drug Market Challenges

Table 4. Chronic Urticaria Or Hives Drug Market Restraints

Table 5. Global Chronic Urticaria Or Hives Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Chronic Urticaria Or Hives Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Chronic Urticaria Or Hives Drug Sales Volume by Company (2019-2024) & (K Pcs)

Table 8. Global Chronic Urticaria Or Hives Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Chronic Urticaria Or Hives Drug Price by Company (2019-2024) & (USD/Pcs)

Table 10. Key Manufacturers Chronic Urticaria Or Hives Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Chronic Urticaria Or Hives Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Chronic Urticaria Or Hives Drug

Table 13. Global Chronic Urticaria Or Hives Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Urticaria Or Hives Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Chronic Urticaria Or Hives Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Chronic Urticaria Or Hives Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Chronic Urticaria Or Hives Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)

Table 22. Global Chronic Urticaria Or Hives Drug Sales Volume by Type (2019-2024) & (K Pcs)

Table 23. Global Chronic Urticaria Or Hives Drug Sales Volume by Type (2025-2030) & (K Pcs)

Table 24. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Chronic Urticaria Or Hives Drug Price by Type (2019-2024) & (USD/Pcs)

Table 27. Global Chronic Urticaria Or Hives Drug Price by Type (2025-2030) & (USD/Pcs)

Table 28. Global Chronic Urticaria Or Hives Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Chronic Urticaria Or Hives Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Chronic Urticaria Or Hives Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Chronic Urticaria Or Hives Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)

Table 34. Global Chronic Urticaria Or Hives Drug Sales Volume by Application (2019-2024) & (K Pcs)

Table 35. Global Chronic Urticaria Or Hives Drug Sales Volume by Application (2025-2030) & (K Pcs)

Table 36. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Chronic Urticaria Or Hives Drug Price by Application (2019-2024) & (USD/Pcs)

Table 39. Global Chronic Urticaria Or Hives Drug Price by Application (2025-2030) & (USD/Pcs)

Table 40. Global Chronic Urticaria Or Hives Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Chronic Urticaria Or Hives Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Chronic Urticaria Or Hives Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Chronic Urticaria Or Hives Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Chronic Urticaria Or Hives Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Chronic Urticaria Or Hives Drug Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030

Table 46. Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2019-2024) & (K Pcs)

Table 47. Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2025-2030) & (K Pcs)

Table 48. Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Chronic Urticaria Or Hives Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Chronic Urticaria Or Hives Drug Average Price by Region (2019-2024) & (USD/Pcs)

Table 51. Global Chronic Urticaria Or Hives Drug Average Price by Region (2025-2030) & (USD/Pcs)

Table 52. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Volume, (2019-2024) & (K Pcs)

Table 56. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Volume, (2025-2030) & (K Pcs)

Table 57. AstraZeneca Plc Company Information

Table 58. AstraZeneca Plc Introduction and Business Overview

Table 59. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 60. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product Offerings

Table 61. AstraZeneca Plc Recent Development

Table 62. Biofrontera AG Company Information

Table 63. Biofrontera AG Introduction and Business Overview

Table 64. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 65. Biofrontera AG Chronic Urticaria Or Hives Drug Product Offerings

Table 66. Biofrontera AG Recent Development

Table 67. ELORAC, Inc. Company Information

Table 68. ELORAC, Inc. Introduction and Business Overview

Table 69. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 70. ELORAC, Inc. Chronic Urticaria Or Hives Drug Product Offerings

Table 71. ELORAC, Inc. Recent Development

Table 72. Faes Farma, SA Company Information

Table 73. Faes Farma, SA Introduction and Business Overview

Table 74. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 75. Faes Farma, SA Chronic Urticaria Or Hives Drug Product Offerings

Table 76. Faes Farma, SA Recent Development

Table 77. Genentech, Inc. Company Information

Table 78. Genentech, Inc. Introduction and Business Overview

Table 79. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 80. Genentech, Inc. Chronic Urticaria Or Hives Drug Product Offerings

Table 81. Genentech, Inc. Recent Development

Table 82. GlaxoSmithKline Plc Company Information

Table 83. GlaxoSmithKline Plc Introduction and Business Overview

Table 84. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 85. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Product Offerings

Table 86. GlaxoSmithKline Plc Recent Development

Table 87. J Uriach Y Compania, S.A. Company Information

Table 88. J Uriach Y Compania, S.A. Introduction and Business Overview

Table 89. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 90. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Product Offerings

Table 91. J Uriach Y Compania, S.A. Recent Development

Table 92. Mabtech Limited Company Information

Table 93. Mabtech Limited Introduction and Business Overview

Table 94. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 95. Mabtech Limited Chronic Urticaria Or Hives Drug Product Offerings

Table 96. Mabtech Limited Recent Development

Table 97. Merck & Co., Inc. Company Information

Table 98. Merck & Co., Inc. Introduction and Business Overview

Table 99. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 100. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Product Offerings

Table 101. Merck & Co., Inc. Recent Development

Table 102. Mycenax Biotech Inc. Company Information

Table 103. Mycenax Biotech Inc. Introduction and Business Overview

Table 104. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 105. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Product Offerings

Table 106. Mycenax Biotech Inc. Recent Development

Table 107. Novartis AG Company Information

Table 108. Novartis AG Introduction and Business Overview

Table 109. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 110. Novartis AG Chronic Urticaria Or Hives Drug Product Offerings

Table 111. Novartis AG Recent Development

Table 112. Panacea Biotec Limited Company Information

Table 113. Panacea Biotec Limited Introduction and Business Overview

Table 114. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)

Table 115. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Product Offerings

Table 116. Panacea Biotec Limited Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Chronic Urticaria Or Hives Drug Downstream Customers

Table 120. Chronic Urticaria Or Hives Drug Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Chronic Urticaria Or Hives Drug Product Picture

Figure 2. Global Chronic Urticaria Or Hives Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Chronic Urticaria Or Hives Drug Sales Volume (2019-2030) & (K Pcs)

Figure 5. Global Chronic Urticaria Or Hives Drug Sales Price (2019-2030) & (USD/Pcs)

Figure 6. Chronic Urticaria Or Hives Drug Report Years Considered

Figure 7. Global Chronic Urticaria Or Hives Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Chronic Urticaria Or Hives Drug Players Sales Volume Ranking (2023) & (K Pcs)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Urticaria Or Hives Drug Revenue in 2023

Figure 10. Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. GDC-0853 Picture

Figure 12. GSK-2646264 Picture

Figure 13. BF-Derm-1 Picture

Figure 14. Bilastine Picture

Figure 15. Others Picture

Figure 16. Global Chronic Urticaria Or Hives Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Chronic Urticaria Or Hives Drug Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Chronic Urticaria Or Hives Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)

Figure 19. Global Chronic Urticaria Or Hives Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Chronic Urticaria Or Hives Drug Price by Type (2019-2030) & (USD/Pcs)

Figure 21. Product Picture of Clinic

Figure 22. Product Picture of Hospital

Figure 23. Product Picture of Others

Figure 24. Global Chronic Urticaria Or Hives Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Chronic Urticaria Or Hives Drug Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Chronic Urticaria Or Hives Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)

Figure 27. Global Chronic Urticaria Or Hives Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Chronic Urticaria Or Hives Drug Price by Application (2019-2030) & (USD/Pcs)

Figure 29. North America Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Chronic Urticaria Or Hives Drug Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Chronic Urticaria Or Hives Drug Sales Volume (%), (2019-2030)

Figure 41. United States Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. China Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. China Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 59. India Chronic Urticaria Or Hives Drug Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Chronic Urticaria Or Hives Drug Sales Value by Type (%), 2023 VS 2030

Figure 61. India Chronic Urticaria Or Hives Drug Sales Value by Application (%), 2023 VS 2030

Figure 62. Chronic Urticaria Or Hives Drug Industrial Chain

Figure 63. Chronic Urticaria Or Hives Drug Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39Q12461

Fri Dec 06 00:00:00 UTC 2024

Add to Cart

Athletes Foot (Tinea pedis) Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-2V6236

Mon Dec 02 00:00:00 UTC 2024

Add to Cart

Dermatology Medical Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31D7671

Mon Dec 02 00:00:00 UTC 2024

Add to Cart

Cutaneous Lupus Erythematosus Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31O13597

Mon Dec 02 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Chronic Urticaria Or Hives Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-6I10118

Chronic Urticaria Or Hives Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Chronic Urticaria Or Hives Drug - Market Size

Chronic Urticaria Or Hives Drug - Market

Report Scope

Scope of Chronic Urticaria Or Hives Drug - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Urticaria Or Hives Drug - Market report?

What are the Application segmentation covered in the Chronic Urticaria Or Hives Drug - Market report?

What are the Type segmentation covered in the Chronic Urticaria Or Hives Drug - Market report?

FEATURED COMPANIES

RELATED REPORTS